Post Reply
181-187 of 187
haha
A bit of activity...watching
wait for strong vol to see a long green bar to resistance 46
better keep this in watchlist to buy
thought they also got simi LB2 drug to fight SARS?...............LB2 Drug in combating Ebola. Ebola is a severe viral disease transmitted from wild
animals to human beings through physical contact, then spreads through human to human contact. LB2 Drug has displayed efficacy at a much lower dose than the only widely used therapeutic agent for Ebola infection.
LB2 Drug demonstrates similar broad efficacy against SARS, MERS, H5N1 Avian Bird Flu, MRSA and Cholera .
We are very encouraged by this result and will continue to forge forward with our research efforts to see results of the LB2 Drug against ZIKA, Malaria and the influenza pandemic.
Our biomedical team is relentless in our efforts for breakthrough results and will continue to work on pre-clinical testing against an array of diseases, including Alzheimer&rsquo s and Parkinson&rsquo s disease, to generate validating laboratory data.
animals to human beings through physical contact, then spreads through human to human contact. LB2 Drug has displayed efficacy at a much lower dose than the only widely used therapeutic agent for Ebola infection.
LB2 Drug demonstrates similar broad efficacy against SARS, MERS, H5N1 Avian Bird Flu, MRSA and Cholera .
We are very encouraged by this result and will continue to forge forward with our research efforts to see results of the LB2 Drug against ZIKA, Malaria and the influenza pandemic.
Our biomedical team is relentless in our efforts for breakthrough results and will continue to work on pre-clinical testing against an array of diseases, including Alzheimer&rsquo s and Parkinson&rsquo s disease, to generate validating laboratory data.
why the stock so weak? i thought they developed simi 3F to fight dengue?.........) Functional Fragrance Formulation (&ldquo 3F&rdquo ), a suite of functional fragrances developed for industrial and medical applications to fight mosquito-borne diseases. Global BioLife has formed a working collaboration with Chemia Corporation (&ldquo Chemia&rdquo ), a speciality
manufacturer specialising in high quality, cost-effective fragrances to manufacture
personal care, household, industrial and institutional products.
Together with Chemia, we have developed a 3F anti-viral spray which have received positive results. We are currently in talks with major corporations on licensing the potential of 3F technologies.
manufacturer specialising in high quality, cost-effective fragrances to manufacture
personal care, household, industrial and institutional products.
Together with Chemia, we have developed a 3F anti-viral spray which have received positive results. We are currently in talks with major corporations on licensing the potential of 3F technologies.
HOT POTENTIAL BIO-TECHS PLAYS